Berberine combined with emodin meaningly inhibited Salt-inducible kinases 3 activity, leading to increased cell cycle arrest, reduced cell growth, and induce apoptosis in breast cancer cells, whereas these effects were not noticed in the nonmalignant breast epithelial cell line. This evidence concerns the gene SIK3 and breast cancer.